22 results match your criteria: "Department of Clinical Neuropharmacology[Affiliation]"
Mov Disord
March 2023
SeniorClinical Scientist - Clinical Development, Denali Therapeutics Inc, South San Francisco, California, USA.
Background: Leucine-rich repeat kinase 2 (LRRK2) inhibition is a promising therapeutic approach for the treatment of Parkinson's disease (PD).
Objective: The aim of this study was to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the potent, selective, CNS-penetrant LRRK2 inhibitor BIIB122 (DNL151) in healthy participants and patients with PD.
Methods: Two randomized, double-blind, placebo-controlled studies were completed.
Pharmaceuticals (Basel)
December 2021
Department of Medical Molecular Informatics, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.
In this study, we used the large number of cases in the FDA adverse-event reporting system (FAERS) database to investigate risk factors for drug-induced hiccups and to explore the relationship between hiccups and gender. From 11,810,863 adverse drug reactions reported between the first quarter of 2004 and the first quarter of 2020, we extracted only those in which side effects occurred between the beginning and end of drug administration. Our sample included 1454 adverse reactions for hiccups, with 1159 involving males and 257 involving females (the gender in 38 reports was unknown).
View Article and Find Full Text PDFEur J Pain
February 2021
Department of Psychosomatic Medicine and Psychotherapy, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.
Background: The term 'visually induced analgesia' describes a reduced pain perception induced by watching the painful body part as opposed to watching a neutral object. In chronic back pain patients, experimental pain, movement-induced pain and habitual pain can be reduced with visual feedback. Visual feedback can also enhance the effects of both massage treatment and manual therapy.
View Article and Find Full Text PDFEur J Pain
January 2019
Department of Psychosomatic Medicine and Psychotherapy, LWL University Hospital, Ruhr-University Bochum, Germany.
Background: Visual analgesia refers to the phenomena where people report decreased pain intensity when they see the painful or painfully stimulated body part. Alongside pain, sensorimotor impairment (i.e.
View Article and Find Full Text PDFEur J Pain
November 2017
Department of Psychosomatic Medicine and Psychotherapy, LWL-University, Ruhr-University Bochum, Bochum, Germany.
Background: Previous findings suggest that watching sites of experimental and chronic pain can exert an analgesic effect. Our present study investigates whether watching one's back during massage increases the analgesic effect of this treatment in chronic back pain patients.
Methods: Twenty patients with chronic back pain were treated with a conventional massage therapy.
Eur J Pain
April 2016
Department of Psychology, University of Koblenz-Landau, Germany.
Background: Chronic back pain (CBP) is a frequent debilitating and often treatment-resistant disorder. The awareness of one's own body seems to be essential in pain reduction through visual input. Visual feedback of the back reduces experimental pain perception in CBP at this site and watching the back during repeated lumbar spine movements reduces movement-evoked pain.
View Article and Find Full Text PDFJ Neurosci
May 2006
Department of Clinical Neuropharmacology, Max Planck Institute of Psychiatry, 80804 Munich, Germany.
It is widely accepted that cannabinoids regulate GABA release by activation of cannabinoid receptor type 1 (CB1). Results obtained from a variety of brain regions consistently indicate that cannabinoid agonists can also reduce glutamatergic synaptic transmission. However, there are still conflicting data concerning the role of CB1 in cannabinoid-induced inhibition of glutamatergic transmission in cortical areas.
View Article and Find Full Text PDFBiol Psychiatry
June 2006
Department of Clinical Neuropharmacology, Pioneer Valley Private Hospital, North Mackay, Queensland, Australia.
Data now exist from which an accurate definition for serotonin toxicity (ST), or serotonin syndrome, has been developed; this has also lead to precise, validated decision rules for diagnosis. The spectrum concept formulates ST as a continuum of serotonergic effects, mediated by the degree of elevation of intrasynaptic serotonin. This progresses from side effects through to toxicity; the concept emphasizes that it is a form of poisoning, not an idiosyncratic reaction.
View Article and Find Full Text PDFCNS Spectr
April 2005
Department of Clinical Neuropharmacology, Max Planck Institute of Psychiatry, Kraepelinstrasse 2, 80804 Munich, Germany.
Neuropathic pain is defined as a chronic pain condition that occurs or persists after a primary lesion or dysfunction of the peripheral or central nervous system. Traumatic injury of peripheral nerves also increases the excitability of nociceptors in and around nerve trunks and involves components released from nerve terminals (neurogenic inflammation) and immunological and vascular components from cells resident within or recruited into the affected area. Action potentials generated in nociceptors and injured nerve fibers release excitatory neurotransmitters at their synaptic terminals such as L-glutamate and substance P and trigger cellular events in the central nervous system that extend over different time frames.
View Article and Find Full Text PDFBiol Psychiatry
September 2004
Department of Clinical Neuropharmacology, Institute of Psychiatry, King's College London, London, United Kingdom.
Background: The -1438A/G single nucleotide polymorphism (SNP) lies just upstream of two alternative promoters for the 5-hydroxytryptamine type 2A (5-HT2A) receptor gene (HTR2A) and is in strong linkage disequilibrium with the 102T/C SNP. Both SNPs are associated with numerous psychiatric disorders and related phenotypes. A possible functional affect of the -1438A/G SNP might underlie associations of both linked SNPs with these neuropsychiatric disorders.
View Article and Find Full Text PDFAnesth Analg
June 2004
From the *Department of Anaesthesiology, Klinikum rechts der Isar, Technische Universität München, and the †Department of Clinical Neuropharmacology, Max-Planck-Institute of Psychiatry, Munich, Germany.
Unlabelled: The minimum alveolar concentration (MAC) of a volatile anesthetic defines anesthetic potency in terms of a suppressed motor response to a noxious stimulus. Therefore, the MAC of an anesthetic might in part reflect depression of motor neuron excitability. In the present study we evaluated the effect of isoflurane (ISO) on neurons in the substantia gelatinosa driven synaptically by putative nociceptive inputs in an in vitro spinal cord preparation of the rat.
View Article and Find Full Text PDFSchizophr Res
November 2002
Department of Clinical Neuropharmacology, Institute of Psychiatry, Denmark Hill, London SE5 8AF, UK.
Clozapine is a potent antagonist of 5-HT3 receptors, which are ligand-gated ion channels that mediate rapid excitatory responses in the central nervous system. Two different isoforms of 5-HT3 receptor subunit genes (HTR3A and HTR3B) have been identified. They have been assigned to chromosome 11q23.
View Article and Find Full Text PDFJ Neurosci
September 2002
Department of Clinical Neuropharmacology, Max-Planck-Institute of Psychiatry, 80804 Munich, Germany.
The synaptic site of expression of long-term potentiation (LTP) and long-term depression (LTD) is still a matter of debate. To address the question of presynaptic versus postsynaptic expression of neocortical LTP and LTD in a direct approach, we measured the glutamate sensitivity of apical dendrites of layer 5 pyramidal neurons during LTP and LTD. We used infrared-guided laser stimulation to release glutamate from its "caged" form with high spatial and temporal resolution.
View Article and Find Full Text PDFNeuroreport
February 1999
Max Planck Institute of Psychiatry, Department of Clinical Neuropharmacology, Munich, Germany.
Little is known regarding opioid receptors in the human cerebellum. The present [11C]diprenorphine PET study investigated opioid receptor binding in the human cerebellum in vivo, and showed a differential binding level in cerebellar cortex, vermis and dentate nuclei. The additional study in vitro of opioid receptors in human cerebellar cortex and rat brain corroborated the presence of opioidergic mechanisms in the human cerebellum in contrast to the rat.
View Article and Find Full Text PDFZ Rheumatol
April 1999
Max-Planck-Institute of Psychiatry, Department of Clinical Neuropharmacology, Munich, Germany.
Integration of nociceptive signaling comprises peripheral, spinal, and supraspinal sites of the nervous system. Various excitatory or inhibitory neurotransmitter and--modulator systems participate in pain processing and modulation. Chronic pain states are associated with functional and structural alterations of nociceptive pathways.
View Article and Find Full Text PDFJ Neurosci Res
July 1998
Max-Planck Institute of Psychiatry, Clinical Institute, Department of Clinical Neuropharmacology, Munich, Germany.
Peripheral noxious stimulation evokes functional and biochemical changes in the spinal cord which results in central sensitization and hyperalgesia, but at the same time also induces the activation of inhibitory control systems. The purpose of the present study was to investigate whether the adaptive changes induced by ongoing peripheral inflammation influence the spinal cord expression of c-Fos (a commonly used marker of neuronal activity) following an additional acute noxious stimulus. Therefore, the spinal expression of c-Fos was immunohistochemically investigated following noxious thermal stimulation of a rat monoarthritic hindpaw at various time points (1, 4, 8, 21 days) after induction of monoarthritis.
View Article and Find Full Text PDFActa Neurol Scand
November 1997
Department of Clinical Neuropharmacology and Neurology, College of Medicine, Sultan Qaboos University, Al-Khod, Muscat-123, Sultanate of Oman.
Background: Impairment of vertical gaze has been attributed to lesions involving the neural structures at the mesodiencephalic level.
Objective: Eye movements were studied in a patient with a unilateral paramedian thalamic infarction documented by MRI.
Case Description: A 63-year-old man presented 3 days after sudden onset vertical diplopia and hypersomnia.
Acta Neurol Belg
March 1997
Department of Clinical Neuropharmacology and Neurology, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman.
Eye movements were studied in two patients with pontine lesions identified by magnetic resonance imaging in one patient and computerized tomography, with neuropathological correlation in another patient. Impairment of ipsilateral saccades were explained by unilateral lesion of the paramedian pontine reticular formation. Ipsilateral dorsolateral and lateral pontine nuclei lesions results in unilateral impairment of smooth pursuit.
View Article and Find Full Text PDFSynapse
January 1997
Department of Clinical Neuropharmacology, Max Planck Institute of Psychiatry, Munich, Germany.
The properties of pre- and postsynaptic GABAB receptors were investigated with intracellular recordings from rat neocortical neurons in vitro. An antagonist of the GABAB receptor (CGP 35348) and ions or drugs interfering with GABAB receptor-mediated K+ conductance (Ba2+, QX 314) were employed to delineate possible differences. CGP 35348 reduced the conductance of the late inhibitory postsynaptic potential (IPSPB) in a dose-dependent manner.
View Article and Find Full Text PDFJ Neurosci Res
February 1995
Department of Clinical Neuropharmacology, Max-Planck-Institut of Psychiatry, Munich, Germany.
Infrared video microscopy of neonatal rat cerebellum (P0-P14) was used to directly visualize migrating granule neurons in relation to other cerebellar cells in a brain slice for up to 24 hr. Initially (P0-P5), granule neurons move along radial migration pathways of other neuronal fibers. These pathways are probably established by the bipolar granule neurons that attach to the external basement membrane via one process and extend another process toward the Purkinje cell layer.
View Article and Find Full Text PDFPain
February 1994
Institute of Histology and Embryology, Faculty of Medicine of Oporto, 4200 PortoPortugal Department of Clinical Neuropharmacology, Max-Planck-Institute for Psychiatry, D-8000 München 40 Germany.
An increase in the number of gamma-aminobutyric acid (GABA)-immunoreactive cells is reported in the superficial dorsal horn of the rat spinal cord upon unilateral inflammation of the hind foot caused by subcutaneous carrageenan injection. The rise of GABAergic cells was restricted to the ipsilateral dorsal horn, reaching a peak value of 23.4% over the contralateral side 4 days after carrageenan injection.
View Article and Find Full Text PDFClin Neuropharmacol
June 1989
Department of Clinical Neuropharmacology, CHU Pontchaillou, Rennes, France.